The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

hbv cirrhosis tx
Jan 15, 2010

40 y.o. hbv hbe- from childhood most of the time inactive hbv with very low hbvdna. on november i found a flare of alt at 500ui/ml (it was probably higher because it was already regressing to low alt/low hbvdna) and fibroscan at 15.9 so started entecavir imediately.I fear resistance very much even if only 1,2% and want to start combination entecavir+tenofovir after 1years of therapy to prevent resistance. most researchers and liver specialsts at harvard are starting considering combo in cirrohsis, do you agree with this combo vs monotherapy? all liver functions are normal, only ggt and alt were abnormal when i had high alt. at 4 weeks of entecavir alt is 58ui/ml and hbvdna 4200ui/ml thank you

Response from Dr. McGovern

As an infectious disease doctor, I tend to think about combination therapy in patients with very high viral loads. However, your viral DNA is already low at 4 weeks of treatment so I suspect you will quickly suppress on this potent drug. As long as your virus is suppressed you will not be at risk for resistance.

immunity confusion HELP plz
HBV Suppression by Treatment

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint